Cargando…

Association between EGFR mutation and expression of BRCA1 and RAP80 in non-small cell lung cancer

Association between the epithelial growth factor receptor (EGFR) mutation and the expression of breast cancer 1 (BRCA1) and receptor-associated protein 80 (RAP80) in non-small cell lung cancer (NSCLC) was studied. From September 2014 to September 2016, 51 patients with NSCLC who were hospitalized in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Xia, Cui, Fangbo, Yin, Huafang, Wu, Dan, Wang, Nanyao, Yuan, Ming, Fei, Yanhua, Wang, Qiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036334/ https://www.ncbi.nlm.nih.gov/pubmed/30008919 http://dx.doi.org/10.3892/ol.2018.8938

Ejemplares similares

USP13 regulates the RAP80-BRCA1 complex dependent DNA damage response
por: Li, Yunhui, et al.
Publicado: (2017)

Loss of BRCA1-A Complex Function in RAP80 Null Tumor Cells
por: Bian, Chunjing, et al.
Publicado: (2012)

When the RAP (80) fades out, you can hear BRCA1 RING
por: Panagopoulos, Andreas, et al.
Publicado: (2021)

RAP80 phase separation at DNA double-strand break promotes BRCA1 recruitment
por: Qin, Caolitao, et al.
Publicado: (2023)

Structural and Functional Implication of RAP80 ΔGlu81 Mutation
por: Vikrant,, et al.
Publicado: (2013)

RAP80 and BRCA1 PARsylation protect chromosome integrity by preventing retention of BRCA1-B/C complexes in DNA repair foci
por: Vohhodina, Jekaterina, et al.
Publicado: (2020)

Co-operation of BRCA1 and POH1 relieves the barriers posed by 53BP1 and RAP80 to resection
por: Kakarougkas, Andreas, et al.
Publicado: (2013)

Venous and Arterial Thromboembolism in Patients with Metastatic Lung Cancer
por: Qin, Ya, et al.
Publicado: (2023)

Customized Treatment in Non-Small-Cell Lung Cancer Based on EGFR Mutations and BRCA1 mRNA Expression
por: Rosell, Rafael, et al.
Publicado: (2009)

Identification of genetic alterations associated with primary resistance to EGFR-TKIs in advanced non-small-cell lung cancer patients with EGFR sensitive mutations
por: Wang, Fang, et al.
Publicado: (2019)

Downregulation of microRNA-122 promotes proliferation, migration, and invasion of human hepatocellular carcinoma cells by activating epithelial–mesenchymal transition
por: Wang, Nanyao, et al.
Publicado: (2016)

MMR-deficiency and BRCA2/EGFR/NTRK mutations
por: Gokare, Prashanth, et al.
Publicado: (2017)

Efficacy of Second-line Tyrosine Kinase Inhibitors in the Treatment of Metastatic Advanced Non-small-cell Lung Cancer Harboring Exon 19 and 21 EGFR Mutations
por: Zheng, Zhen, et al.
Publicado: (2017)

RAP80 is an independent prognosis biomarker for the outcome of patients with esophageal squamous cell carcinoma
por: Yang, Qingyuan, et al.
Publicado: (2018)

TRAIP/RNF206 is required for recruitment of RAP80 to sites of DNA damage
por: Soo Lee, Nam, et al.
Publicado: (2016)

RAP80 regulates epithelial–mesenchymal transition related with metastasis and malignancy of cancer
por: Park, Song Yi, et al.
Publicado: (2016)

AT-101 enhances gefitinib sensitivity in non-small cell lung cancer with EGFR T790M mutations
por: Zhao, Ren, et al.
Publicado: (2016)

Case report: Concomitant EGFR mutation and ALK rearrangement in non-small cell lung cancer
por: Hu, Haoyue, et al.
Publicado: (2023)

Poor Prognosis With Coexistence Of EGFR T790M Mutation And Common EGFR-Activating Mutation In Non- Small Cell Lung Cancer
por: Gao, Xuejuan, et al.
Publicado: (2019)

Ubiquitin-interaction motifs of RAP80 are critical in its regulation of estrogen receptor α
por: Yan, Jun, et al.
Publicado: (2007)

RAP80 expression in breast cancer and its relationship with apoptosis in breast cancer cells
por: Jin, Guanghua, et al.
Publicado: (2019)

A meta-analysis of adjuvant EGFR-TKIs for patients with EGFR mutation of resected non-small cell lung cancer
por: Cui, Ran, et al.
Publicado: (2022)

EGFR mutations subset in Chinese lung squamous cell carcinoma patients
por: Sun, Ying, et al.
Publicado: (2018)

Plasma EGFR mutation abundance affects clinical response to first-line EGFR-TKIs in patients with advanced non-small cell lung cancer
por: Wang, Xiaohong, et al.
Publicado: (2021)

SMARCA4‑deficient non‑small cell lung cancer with an EGFR mutation: A case report
por: Sun, Lijun, et al.
Publicado: (2023)

Cytoplasmic RAP1 mediates cisplatin resistance of non-small cell lung cancer
por: Xiao, Lu, et al.
Publicado: (2017)

Combined Small and Squamous Transformation in EGFR-mutated Lung Adenocarcinoma
por: Hakozaki, Taiki, et al.
Publicado: (2020)

Serum exosomal microRNAs as predictive markers for EGFR mutations in non–small‐cell lung cancer
por: Xia, Junbo, et al.
Publicado: (2021)

Intrinsic resistance to EGFR tyrosine kinase inhibitors in advanced non-small-cell lung cancer with activating EGFR mutations
por: Wang, Jun, et al.
Publicado: (2016)

EGFR-Mutated Squamous Cell Lung Cancer and Its Association With Outcomes
por: Jin, Rui, et al.
Publicado: (2021)

EGFR exon 20 insertion mutations in non-small cell lung cancer
por: Wang, Fenfang, et al.
Publicado: (2020)

Effect of EGFR amplification on the prognosis of EGFR-mutated advanced non–small-cell lung cancer patients: a prospective observational study
por: Peng, Duanyang, et al.
Publicado: (2022)

EGFR-Targeted Therapy for Non-Small Cell Lung Cancer: Focus on EGFR Oncogenic Mutation
por: Antonicelli, Alberto, et al.
Publicado: (2013)

Comparation of EGFR-TKI (EGFR tyrosine kinase inhibitors) combination therapy and osimertinib for untreated EGFR-mutated advanced non-small cell lung cancers: A systematic review and network meta-analysis
por: Lei, Yang, et al.
Publicado: (2023)

EGFR-dependent pancreatic carcinoma cell metastasis via Rap1 activation
por: Huang, Miller, et al.
Publicado: (2011)

EGFR mutations as a prognostic and predictive marker in non-small-cell lung cancer
por: Fang, Shu, et al.
Publicado: (2014)

Detection of EGFR mutations in non-small cell lung cancer by droplet digital PCR
por: Williamson, Drew F. K., et al.
Publicado: (2022)

EGFR T790M mutation after chemotherapy for small cell lung cancer transformation of EGFR-positive non-small cell lung cancer
por: Sonoda, Tomoaki, et al.
Publicado: (2018)

A Primary Lung and Breast Cancer Patient with Germline EGFR R776H Mutation: A Case Report and Literature Review
por: Li, Dan, et al.
Publicado: (2023)

Insights into EGFR Mutations and Oncogenic KRAS Mutations in Non-Small-Cell Lung Cancer
por: Rosell, Rafael, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hqe4qg9klu9r0es5lonivabobd